| 2D Structure | |
| CID | 62884 |
| IUPAC Name | 2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one;hydrochloride |
| InChI | InChI=1S/C13H18ClNO.ClH/c1-9(15-13(2,3)4)12(16)10-6-5-7-11(14)8-10;/h5-9,15H,1-4H3;1H |
| InChI Key | HEYVINCGKDONRU-UHFFFAOYSA-N |
| Canonical SMILES | None |
| Isomeric SMILES | None |
| Molecular Formula | C13H19Cl2NO |
| Molecular Weight | 276.20 |
| synonyms | ['Bupropion hydrochloride', '31677-93-7', 'Bupropion Hcl', 'Amfebutamone hydrochloride', 'Wellbutrin XL', 'Wellbutrin SR', 'Forfivo XL', 'Mysimba', 'Budeprion XL', 'BW 323', 'ZG7E5POY8O', 'NSC-315851', 'DTXSID6044561', 'BW323', 'BW-323', 'DTXCID4024561', 'NSC315851', 'CONTRAVE COMPONENT BUPROPION HYDROCHLORIDE', 'Appbutamone', 'Forfivo', 'extended-release', 'Appbutamone-D', 'Bupropion XL', 'Wellbutrin 75', 'Wellbutrin 100', 'BUPROPION HCL ER', 'buPROpion HydrochlorideXL', 'Bupropion Hydrochloride ER', 'Bupropion Hydrochloride SR', 'Bupropion Hydrochloride XL', 'Bupropion HCL ER (XL)', 'BUPROPION HCL ER XL', 'Bupropion Hydrochloridexl XL', 'Bupropion Hydrochloride (sr)', 'Bupropion Hydrochloride (xl)', 'BUPROPION HCL ER (SR)', 'Bupropion Hydrochloride SR (sr)', 'BW 323U66', 'Bupropion Hydrochloride Extended Release', 'BUPROPION HYDROCHLORIDE, TYROSINE', 'Bupropion Hydrochloride Extended Release (xl)', '(+-)-1-(3-Chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone Hydrochloride', '2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one hydrochloride', 'Wellbutrin', 'Zyban', 'Amfebutamone (Bupropion) HCl', 'Budeprion', 'Wellbatrin', 'Bupropion (hydrochloride)', "2-(tert-Butylamino)-3'-chloropropiophenone hydrochloride", 'Bupropion SR', 'MFCD00055209', '31677-93-7 (HCl)', 'Bupropion.HCl', '2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one;hydrochloride', '1-(3-CHLOROPHENYL)-2-[(1,1-DIMETHYLETHYL)AMINO]-1-PROPANONE HYDROCHLORIDE', '234447-17-7', 'Bupropion hydrochloride 100 microg/mL in Acetonitrile', 'Zyban (pharmaceutical)', 'Voxra', '(+/-)-Bupropion; Amfebutamon; Amfebutamone; Aplenzin; Bupropion SR; Bupropion XL', '1-Propanone, 1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]-, hydrochloride (1:1), (-)-', 'SMR000058423', 'Budeprion XL 300', 'Amfebutamon hydrochloride', 'SR-01000002989', 'EINECS 250-759-9', 'UNII-ZG7E5POY8O', 'NSC 315851', 'Quomem', 'Bupropion hydrochloride [USAN]', 'Wellbutrin XR', 'Wellbutrin Retard', 'Wellbutrin (TN)', 'Prestwick_668', 'EINECS 252-243-9', 'Zyban (TN)', 'm-Chloro-alpha-tert-butylaminopropiophenone hydrochloride', 'alpha-(tert-Butylamino)-m-chloropropiophenone hydrochloride', 'm-Chloro-alpha-tert-butylaminopropionphenone hydrochloride', 'Bupropion hydrochloride [USAN:USP:JAN]', "(+-)-2-(tert-Butylamino)-3'-chloropropiophenone hydrochloride", '(+-)-alpha-tert-Butylamino-3-chloropropiophenone hydrochloride', 'Amfebutamone (Bupropion)', 'NCGC00016807-01', 'CAS-31677-93-7', 'CHEMBL1698', 'SCHEMBL41602', 'MLS000069376', 'MLS001401370', 'MLS002320678', 'SPECTRUM1504174', 'CHEBI:3220', 'SCHEMBL29420039', 'HY-B0403A', 'BVF 033', 'BW 322U', 'CPI-300', 'HMS1568B20', 'HMS1922F09', 'HMS5081I05', 'Pharmakon1600-01504174', 'Bupropion HCl - Bio-X trade mark', 'Bupropion hydrochloride (JAN/USP)', 'BCP22394', 'MSK10349', 'BUPROPION HYDROCHLORIDE [MI]', 'Tox21_110621', 'Tox21_301844', 'Tox21_500166', 'AC-196', 'Amfebutamone-hydrochloride(Bupropion)', 'BUPROPION HYDROCHLORIDE [JAN]', 'BW-323U66', 'CCG-39085', 'NSC758686', "Propiophenone, 2-(tert-butylamino)-3'-chloro-, hydrochloride, (+-)-", 'BUPROPION HYDROCHLORIDE [HSDB]', 'AKOS015844544', 'Tox21_110621_1', 'AB02273', 'BCP9000462', 'BUPROPION HYDROCHLORIDE [MART.]', 'BUPROPION HYDROCHLORIDE [VANDF]', 'CCG-100911', 'FB61552', 'KS-1034', 'LP00166', 'NC00161', '(+/-)-1-(3-Chlorophenyl)-2-[(1,1-dimethylethyl)amino]-1-propanone hydrochloride', '1-Propanone, 1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)-, hydrochloride, (+-)-', 'BUPROPION HYDROCHLORIDE [USP-RS]', 'BUPROPION HYDROCHLORIDE [WHO-DD]', 'NCGC00015122-11', 'NCGC00093650-01', 'NCGC00093650-02', 'NCGC00093650-03', 'NCGC00093650-04', 'NCGC00093650-05', 'NCGC00180895-01', 'NCGC00180895-02', 'NCGC00255927-01', 'NCGC00260851-01', 'Propiophenone, hydrochloride, (.+-.)-', 'BB164268', 'SMR001338824', 'BCP0726000049', 'B-102', 'B3649', 'BUPROPION HYDROCHLORIDE [ORANGE BOOK]', 'EU-0100166', 'NS00088186', 'S2452', 'SW196823-6', 'BUPROPION HYDROCHLORIDE [USP IMPURITY]', 'BUPROPION HYDROCHLORIDE [USP MONOGRAPH]', 'D00817', 'AUVELITY COMPONENT BUPROPION HYDROCHLORIDE', 'Bupropion hydrochloride, >=98% (HPLC), solid', 'EN300-1707780', 'SR-01000002989-2', 'Q27295463', 'SR-01000002989-10', 'Z1741979718', "(+/-)-2-(t-butylamino)-3'-chloropropiophenone hydrochloride", '1-Propanone,1-dimethylethyl)amino]-, hydrochloride, (.+-.)-', 'Bupropion Hydrochloride 1.0 mg/ml in Methanol (as free base)', "(+/-)-2-(tert-butylamino)-3'-chloropropiophenone hydrochloride", "(.+-.)-2-(tert-Butylamino)-3'-chloropropiophenone hydrochloride", '2-(tert-Butylamino)-1-(3-chlorophenyl)-1-propanone Hydrochloride', 'Bupropion.HCl, 1mg/ml in Acetonitrile/Water : 1/1 (as free base)', 'Bupropion hydrochloride, United States Pharmacopeia (USP) Reference Standard', '1-(3-CHLOROPHENYL)-2-[(1,1-DIMETHYLETHYL)AMINO]-1-PROPANE, MONOHYDROCHLORIDE', '1-Propanone, 1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]-, hydrochloride (1:1)', 'Bupropion Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material', '( inverted question mark)-1-(3-Chlorophenyl)-2-[(1,1-dimethylethyl)amino]-1-propanone hydrochloride', '1-PROPANONE, 1-(3-CHLOROPHENYL)-2-((1,1-DIMETHYLETHYL)AMINO)-, HYDROCHLORIDE, (+/-)-'] |
From Pubchem